WhiteSwell Medical

Company Overview

Snapshot

Founded in September 2014, WhiteSwell Medical operates with 11–50 employees. The company has raised $30M across one funding round from 2 investors. In December 2020, WhiteSwell Medical strengthened its patent portfolio for the treatment of Acute Decompensated Heart Failure with a newly issued U.S. patent.

Business overview

WhiteSwell Medical is a science-driven company focused on improving the treatment of acute decompensated heart failure (ADHF), a major contributor to repeat hospitalizations and emergency room visits. The company is developing a minimally invasive, catheter-based approach designed to enhance the lymphatic system's natural fluid-removal process, thereby more efficiently removing excess interstitial fluid in ADHF patients. Operating within the Health Tech & Life Sciences sector, WhiteSwell Medical specializes in medical devices and medical treatment & therapeutics.

Strategic signal

In January 2022, WhiteSwell Medical appointed experienced executives to its senior management team. This move signals a strategic intent to bolster leadership and operational capabilities, likely in preparation for advanced product development, clinical trials, or market expansion, indicating a period of growth and organizational scaling for the company.

Company Intelligence Q&A

What is WhiteSwell Medical's primary focus?

WhiteSwell Medical is dedicated to improving the treatment of acute decompensated heart failure (ADHF), a significant cause of repeat hospitalizations.

When was WhiteSwell Medical founded?

WhiteSwell Medical was founded in September 2014.

What technology is WhiteSwell Medical developing?

WhiteSwell Medical is developing a minimally invasive, catheter-based approach to more efficiently remove excess interstitial fluid in ADHF patients by enhancing the lymphatic system's natural fluid-removal process.

Did WhiteSwell Medical recently strengthen its intellectual property?

In December 2020, WhiteSwell Medical strengthened its patent portfolio for the treatment of Acute Decompensated Heart Failure with a newly issued U.S. patent.

Has WhiteSwell Medical made recent changes to its leadership team?

In January 2022, WhiteSwell Medical added experienced executives to its senior management team.